Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

446 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The impact of central IRB's on informed consent readability and trial adherence in SPRINT.
Tamariz L, Gajardo M, Still CH, Gren LH, Clark E, Walsh S, Whittle J, Nord J, Ramsey T, Contreras G; SPRINT Research Group. Tamariz L, et al. Among authors: contreras g. Contemp Clin Trials Commun. 2019 Jul 6;15:100407. doi: 10.1016/j.conctc.2019.100407. eCollection 2019 Sep. Contemp Clin Trials Commun. 2019. PMID: 31338481 Free PMC article.
Baseline blood pressure control in Hispanics: characteristics of Hispanics in the Systolic Blood Pressure Intervention Trial.
Rodriguez CJ, Still CH, Garcia KR, Wagenknecht L, White S, Bates JT, Del Cid MV, Lioudis M, Lopez Barrera N, Moreyra A, Punzi H, Ringer RJ, Cushman WC, Contreras G, Servilla K, Rocco M; SPRINT Research Group. Rodriguez CJ, et al. Among authors: contreras g. J Clin Hypertens (Greenwich). 2017 Feb;19(2):116-125. doi: 10.1111/jch.12942. Epub 2016 Nov 14. J Clin Hypertens (Greenwich). 2017. PMID: 27862904 Free PMC article. Clinical Trial.
Outcomes in adults with systolic blood pressure between 130 and 139 mmHg in Action to Control Cardiovascular Risk in Diabetes Blood Pressure trial and Systolic Blood Pressure Intervention Trial.
Contreras G, Lu L, Tamariz L, Rocco MV, Papademetriou V, Kostis JB, Pisoni R, Glasser SP, Sweeney ME, Basile J, Gren LH, Zamanian S, Cushman WC; SPRINT Research Group. Contreras G, et al. J Hypertens. 2020 Aug;38(8):1567-1577. doi: 10.1097/HJH.0000000000002437. J Hypertens. 2020. PMID: 32371767
Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial.
Still CH, Craven TE, Freedman BI, Van Buren PN, Sink KM, Killeen AA, Bates JT, Bee A, Contreras G, Oparil S, Pedley CM, Wall BM, White S, Woods DM, Rodriguez CJ, Wright JT Jr; SPRINT Study Research Group. Still CH, et al. Among authors: contreras g. J Am Soc Hypertens. 2015 Sep;9(9):670-9. doi: 10.1016/j.jash.2015.06.012. Epub 2015 Aug 7. J Am Soc Hypertens. 2015. PMID: 26320890 Free PMC article.
Recurrence of lupus nephritis after kidney transplantation.
Contreras G, Mattiazzi A, Guerra G, Ortega LM, Tozman EC, Li H, Tamariz L, Carvalho C, Kupin W, Ladino M, LeClercq B, Jaraba I, Carvalho D, Carles E, Roth D. Contreras G, et al. J Am Soc Nephrol. 2010 Jul;21(7):1200-7. doi: 10.1681/ASN.2009101093. Epub 2010 May 20. J Am Soc Nephrol. 2010. PMID: 20488956 Free PMC article.
Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.
Beddhu S, Shen J, Cheung AK, Kimmel PL, Chertow GM, Wei G, Boucher RE, Chonchol M, Arman F, Campbell RC, Contreras G, Dwyer JP, Freedman BI, Ix JH, Kirchner K, Papademetriou V, Pisoni R, Rocco MV, Whelton PK, Greene T. Beddhu S, et al. Among authors: contreras g. J Am Soc Nephrol. 2019 Aug;30(8):1523-1533. doi: 10.1681/ASN.2018121261. Epub 2019 Jul 19. J Am Soc Nephrol. 2019. PMID: 31324734 Free PMC article. Clinical Trial.
446 results